Qianhui Tang
State Key Laboratory Of Natural Medicines
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Unveiling a novel macrophage-driven mechanism for obeticholic acid-induced liver injury in cholestatic: targeting NLRP12Arg185 fuels Relb-TNFSF14-mediated ductular reaction.
Journal: Cell biology and toxicology
Published: December 07, 2025
Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P/phosphorylated signal transducer and activator of transcription 3 axis.
Journal: The Journal of pharmacology and experimental therapeutics
Published: October 18, 2025
Obeticholic acid exacerbates liver injury through hepatocyte-mediated release of HMGB1 by inducing lysosomal membrane permeabilization in cholestasis.
Journal: Chemico-biological interactions
Published: May 22, 2025
Immune-endothelial cell crosstalk in hepatic endothelial injury of liver fibrotic mice.
Journal: European journal of pharmacology
Published: December 27, 2024
Group 1 innate lymphoid cell activation via recognition of NKG2D and liver resident macrophage MULT-1: Collaborated roles in triptolide induced hepatic immunotoxicity in mice.
Journal: Ecotoxicology and environmental safety
Published: October 09, 2023
Triptolide leads to hepatic intolerance to exogenous lipopolysaccharide and natural-killer-cell mediated hepatocellular damage by inhibiting MHC class I molecules.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 12, 2022
Th17/Treg imbalance mediates hepatic intolerance to exogenous lipopolysaccharide and exacerbates liver injury in triptolide induced excessive immune response.
Journal: Journal of ethnopharmacology
Published: April 05, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026